INS and type 1 diabetes mellitus: The landmark Diabetes Control and Complications (DCCT) trial found that the use of intensive insulin therapy in T1D reduced the risk of long-term microvascular complications, but that intensive therapy also increased the risk of hypoglycaemia [3].